BioLineRx Stock Forecast

Stock Price Forecast

The 2 analysts that cover BioLineRx stock have a consensus rating of "Strong Buy" and an average price target of $19, which forecasts a 737.00% increase in the stock price over the next year. The lowest target is $12 and the highest is $26.

Price Target: $19 (+737.00%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$12	$19	$26	$26
Change	+428.63%	+737.00%	+1045.4%	+1045.4%

* Price targets were last updated on Jun 17, 2025.

Analyst Ratings

The average analyst rating for BioLineRx stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	2	2	2	1	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	1	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $26	Strong Buy	Reiterates	$26	+1,045.37%	Jun 17, 2025
Justin Walsh Jones Trading	Jones Trading	Hold → Strong Buy Upgrades $12	Hold → Strong Buy	Upgrades	$12	+428.63%	May 30, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $26	Strong Buy	Reiterates	$26	+1,045.37%	May 28, 2025
Justin Walsh Jones Trading	Jones Trading	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Apr 2, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $9 → $26	Strong Buy	Maintains	$9 → $26	+1,045.37%	Mar 31, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 1.18M

Revenue Next Year

n/a

EPS This Year

n/a

from -0.00

EPS Next Year

n/a

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Revenue	-	-	4.80M	28.94M	1.18M
Revenue Growth	-	-	-	502.92%	-95.92%
EPS	-0.04	-0.03	-0.06	-0.01	-0.00
EPS Growth	-	-	-	-	-
Forward PE	-	-	-	-	-
No. Analysts	-	-	-	-	-

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue
High
Avg
Low

Revenue Growth

Revenue Growth
High
Avg
Low

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.